Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) FCF Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed FCF Margin for 15 consecutive years, with 6.05% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin fell 1670.0% to 6.05% in Q3 2025 year-over-year; TTM through Sep 2025 was 2.05%, a 557.0% decrease, with the full-year FY2024 number at 5.96%, down 14.0% from a year prior.
  • FCF Margin was 6.05% for Q3 2025 at Usana Health Sciences, down from 5.17% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 13.28% in Q4 2022 to a low of 93465.62% in Q4 2022.
  • A 5-year average of 5492.79% and a median of 5.26% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: soared 9347275bps in 2023, then tumbled -1670bps in 2025.
  • Usana Health Sciences' FCF Margin stood at 5.86% in 2021, then soared by 126bps to 13.28% in 2022, then plummeted by -36bps to 8.46% in 2023, then plummeted by -78bps to 1.86% in 2024, then crashed by -424bps to 6.05% in 2025.
  • Per Business Quant, the three most recent readings for USNA's FCF Margin are 6.05% (Q3 2025), 5.17% (Q2 2025), and 6.19% (Q1 2025).